Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherven Sharma

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Plos One|July 19, 2012
Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of miceUpendra K Kar, Janina Jiang, Cheryl I Champion, et al.
JTO Clinical and Research Reports|November 22, 2021
Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLCPuja Shahrouki, Jay M Lee, Jonathan Barclay, et al.
Acta Pharmaceutica Sinica. B|June 7, 2021
Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasisZhiyao Xu, Zhuha Zhou, Jing Zhang, et al.
Immunotargets and Therapy|May 3, 2014
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancerMinu K Srivastava, Li Zhu, Marni Harris-White, et al.
Autoimmunity Reviews|July 18, 2013
The role of miRNA in inflammation and autoimmunityRam Pyare Singh, Israel Massachi, Sudhir Manickavel, et al.
Molecular Cancer|May 13, 2003
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10Sherven Sharma, Seok-Chul Yang, Sven Hillinger, et al.
Scientific Reports|August 25, 2017
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBLYi-Hung Carol Tan, Tamara Mirzapoiazova, Brian M Won, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responsesSherven Sharma, Li Zhu, Seok Chul Yang, et al.
Journal of Cancer Science & Therapy|November 3, 2015
Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant PathwayMi-Heon Lee, Puja Kachroo, Paul C Pagano, et al.
Oncoimmunology|July 3, 2015
GITR agonist enhances vaccination responses in lung cancerLi X Zhu, Michael Davoodi, Minu K Srivastava, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Plos One|July 19, 2012
Vault nanocapsules as adjuvants favor cell-mediated over antibody-mediated immune responses following immunization of miceUpendra K Kar, Janina Jiang, Cheryl I Champion, et al.
JTO Clinical and Research Reports|November 22, 2021
Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLCPuja Shahrouki, Jay M Lee, Jonathan Barclay, et al.
Acta Pharmaceutica Sinica. B|June 7, 2021
Targeting BMI-1-mediated epithelial-mesenchymal transition to inhibit colorectal cancer liver metastasisZhiyao Xu, Zhuha Zhou, Jing Zhang, et al.
Immunotargets and Therapy|May 3, 2014
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancerMinu K Srivastava, Li Zhu, Marni Harris-White, et al.
Autoimmunity Reviews|July 18, 2013
The role of miRNA in inflammation and autoimmunityRam Pyare Singh, Israel Massachi, Sudhir Manickavel, et al.
Molecular Cancer|May 13, 2003
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10Sherven Sharma, Seok-Chul Yang, Sven Hillinger, et al.
Scientific Reports|August 25, 2017
Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBLYi-Hung Carol Tan, Tamara Mirzapoiazova, Brian M Won, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responsesSherven Sharma, Li Zhu, Seok Chul Yang, et al.
Journal of Cancer Science & Therapy|November 3, 2015
Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant PathwayMi-Heon Lee, Puja Kachroo, Paul C Pagano, et al.
Oncoimmunology|July 3, 2015
GITR agonist enhances vaccination responses in lung cancerLi X Zhu, Michael Davoodi, Minu K Srivastava, et al.
Pageof 11